Skip to content

One night of partial sleep restriction: effects on metabolism, mood, and stress responsiveness

One night of partial sleep restriction: effects on metabolism, mood, and stress responsiveness

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25362
Enrollment
36
Registered
2016-04-06
Start date
2016-05-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep

Interventions

One night of short sleep (4h) will be compared to one night of normal sleep (8h).

Sponsors

Leiden University Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Informed consent - Male Caucasian - Age between 18 and 55 years - BMI between 20 and 35 kg/m2

Exclusion criteria

Exclusion criteria: - Active endocrine disease (e.g. diabetes mellitus type 1 and type 2, thyroid disease, any signs of Cushing’s syndrome, adrenal disease and lipid-associated disorders such as FH) - Fasting glucose >7.0 mmol/L - Severe chronic disease (e.g. chronic liver or kidney disease) - Severe insomnia, sleep disorders or exceptional habitual sleep duration (10 h). - Medication use including the following: lipid lowering drugs, glucocorticoids, sleep medication, hormone replacement, glucose lowering drugs, insulin therapy, antidepressants and psychotropic drugs (last 6 weeks)), anti-coagulants - Recent time zone travel (last 6 weeks) - Shift work (last 6 weeks) - Severe alcohol use (>21 units/week) - Psychiatric disease - Drug abuse - Recent participation to another nutritional or biomedical trial (last 6 weeks) - Medication use which may interfere with study measurements, as judged by the responsible physician - Reported weight loss or weight gain (10%) in the last six months prior to the pre-study screening - Clinically relevant abnormalities in clinical chemistry at screening (to be judged by the study physician) - Reported use of any nicotine containing products in the six months preceding the study and during the study itself; - Extreme strenuous exercise during last 3 months, as judged by responsible physician - Excessive sunbathing during last 3 months, as judged by responsible physician.

Design outcomes

Primary

MeasureTime frame
- Metabolic flexibility; measured as change in RQ and lipid levels after a standard meal - Stress responsiveness; measured as change in stress hormones, heart rate and blood pressure after a mild physical stressor

Secondary

MeasureTime frame
- Tissue ageing; measured in skin - Intracellular metabolic pathways; measured in subcutaneous white fat and skeletal muscle tissue - Circadian rhythm in hormone and skin temperature rhythms

Contacts

Public ContactRosa van den Berg

Albinusdreef 2 / 2333 ZA Leiden

R.van_den_Berg.ENDO@lumc.nl0031 (0) 71- 5268172

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)